Axillary assessment in breast cancer patients
Not Applicable
Completed
- Conditions
- Axillary assessment in breast cancer patientsCancer
- Registration Number
- ISRCTN89098304
- Lead Sponsor
- Hawler Medical University
- Brief Summary
2023 Preprint results in https://doi.org/10.21203/rs.3.rs-2578478/v1 (added 14/11/2023)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 180
Inclusion Criteria
Women with histologically confirmed breast cancer
Exclusion Criteria
1. A prior diagnosis of breast cancer who had undergone any type of neoadjuvant treatment or surgical procedure
2. Breast cancer patients planned for neoadjuvant chemotherapy
3. History of lymphoma or other malignancies
4. Pregnancy or breastfeeding
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evidence of any breast lesion and its features, location, and dimensions measured using ultrasound versus histopathology at one timepoint
- Secondary Outcome Measures
Name Time Method Accuracy (sensitivity, specificity, positive predictive value, negative predictive value) of diagnosing metastatic lymph nodes measured using axillary ultrasound at one timepoint